Extracorporeal CO2 Removal Devices Market Synopsis

Extracorporeal CO2 Removal Devices Market Size Was Valued at USD 102.53 Million in 2023 and is Projected to Reach USD 170.31 Million by 2032, Growing at a CAGR of 5.8% From 2024-2032.

The trend for ECMO devices has rapidly escalated over the recent past, due to the increase in the incidences of respiratory ailments including acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD) and other complications related to these diseases. These devices are potentially beneficial particularly regarding acute or chronic respiratory failure, acting effectively in the removal of CO2 from the blood stream in order to achieve the optimal gas exchange.

• This makes it easy to explain why there is high incidences of respiratory disorders across the globe, enhanced by ageing population that is often at high risk of developing such diseases, all of which explains why there is high demand for extracorporeal CO2 removal devices.
• Advancements in technology have saw the creation of advanced and efficient devices in the removal of CO2 from the body especially in cases where the patients are on the ventilators thus increasing its usage in the health facilities.
• Some of the factors that have powerfully shaped the Extracorporeal CO2 Removal Therapy market growth include increased awareness among the clinicians about the utility and use of the therapy intervention, alongside with further extensions to the use in the intensive care units and critical care section.
• Moreover, favourable industry policies and reimbursement structures in developed countries are also helping the market expand as this leads to more investment from healthcare providers into premium respiration supportive technologies.

Extracorporeal CO2 Removal Devices Market Trend Analysis

Technological Advancements

• New formulation of membrane technology has allowed for higher effective and more long-lasting membranes of extracorporeal CO2 removal equipment. Thus, reducing the thickness of these membranes results in increased permeability in terms of gas exchange, while keeping the biocompatibility factor into consideration, which makes the devices more effective and reliable.
• One advantage of miniaturization of ECMO devices is portability, which can be helpful for determined specialisms like intensive care units, operating rooms, and even ambulances. Carry-over devices allow for continual respiratory support beyond the hospital and producing upswings to other facilities, making treatment earlier and considerably more effective.
• The combination of ECMO devices with modern monitoring systems enables the assessment of changes in blood parameters of the patient’s condition, coagulation properties, gases, etc. This allows for the better institution of dose adjustments in therapy, improving the management of patient outcomes and a decrease in complication occurrences.
• The technological opportunities of modern technology support effective telemonitoring and telecommunication, thus, allowing the healthcare providers to monitor the process of patient therapy, as well as to cooperate with other specialists in cases when the necessary experience is required. This improves the possibility of using telemedicine for various applications and the availability of EC-CO2 removal therapy, especially in areas with limited facility.

Increasing Prevalence of Respiratory Diseases

• Damaging effects of severe respiratory diseases like the acute respiratory distress syndrome (ARDS), Chronic Obstructive Pulmonary Disease (COPD) and their exacerbations, have increased the need for evaluated extracorporeal CO2 removal devices in the management of respiratory failure.
• Given the rising incidence of respiratory disorders, there is a growing set of conditions that may call for E CO2 R therapy. These devices are being employed on the growing popularity not only in Intensive Care Units and operating rooms but also in intermediate care units during procedures which could be potentially complicated by the patients’ impaired lung function.
• The increasing incidents of respiratory ailments indicate that physicians should consider patient-specific factors. The devices which help in removal of CO2 from patient’s external circulation provide an opportunity to the clinicians to actually address the cause of the disease in a particular patient and design interventions as per the disease progression in the concerned patient.

Extracorporeal CO2 Removal Devices Market Segment Analysis:

Extracorporeal CO2 Removal Devices Market is segmented on the basis of Product, Application and End-User

By Product, Extracorporeal CO2 machines segment is expected to dominate the market during the forecast period.

• The availability of technologically advanced wearable and mobile ECMCO2R, particularly for ICU applications, is strengthening the global market growth. New products are intended to be more efficient, have better monitoring features, and convenient interfaces to ensure optimal effectiveness of the device in patients’ treatment and smooth integration into clinical practice.
• Extracorporeal CO2 removal has created a need to use disposable parts which is an ideal market for the production of such goods. Disposable tubing sets, oxygenators, and filters Contribute to the safety and reliable delivery of therapy reducing the incidences of cross-contamination and infections that fuels the market growth of this product type.
• The opportunities in the global market for extracorporeal CO2 removal devices are also affected by growth in the allied products which includes but are not limited to catheters, cannulas and vascular access devices. In this manner, these products have a vital function of enhancing the delivery of therapy and achieving patient satisfaction and safety that drives the market.
• As with most medical equipment and technology niches, cost containment has become the new buzzword since the battle to reign in escalating healthcare expenses continues to intensify, therefore the cost-effective extracorporeal CO2 removal devices possible. Current strategies involving lowering the cost per treatment includes creating packages and part produced for more than one use in an effort to gain penetration in the market in terms of competitiveness.

By Application, Acute Respiratory Distress Syndrome (ARDS) segment held the largest share in 2023

• Extracorporeal CO2 removal is commonly applied in the management of acute respiratory distress syndrome (ARDS), thus contributing to this market’s expansion. ARDS is a form of acute lung dysfunction accompanied by severe lung inflammation and respiratory failure that may require ECLS as a mode of support for oxygenation/carbon dioxide removal. The rise in the number of patients diagnosed with ARDS, in particular in Intensive Care Units, contributes to the need for a variety of technologies for ECCO2R in respiratory support.
• Another instance in which ECR is employed is in Chronic Obstructive Pulmonary Disease (COPD). COPD is a lung disease involving the gradual narrowing of airways and progressive dyspnoea. When the traditional therapies fail to meet the quality of the candidates, devices aimed at extracorporeal CO2 removal can offer a temporary help and support for the patient’s lungs, increase levels of oxygen, and reduce the severity of the symptoms, thus increasing the life quality of the patient.
• Extra Corporeal CO2 Removal Devices have been found to be valuable and as a support for patients awaiting lung transplantation due to end-stage lung disorders. These devices can be used to stabilise patients with severe respiratory failure while waiting for LOV, amplifying their physiological status, as well as enhancing graft useful lives.
• Besides ARDS, COPD, and BVLT, some place is looking into ECO2R for the other potential indication) such as respiratory failure in certain lung diseases, cardiothoracic surgery perioperative period, and lung protective ventilation in the critically ill population.

Extracorporeal CO2 Removal Devices Market Regional Insights:

Asia-Pacific is expected to witness significant growth during the forecast period.

• In the Asia-Pacific region, there are increasing trends in hospitalized patients having respiratory diseases like COPD, ARDS, and acute-on-chronic respiratory failure occurring due to infectious diseases like pneumonia. This increasing disease burden is contributing to the need to adopt newer and more sophisticated forms of respiratory support such as extracorporeal CO2 removal equipments.
• It is evident that countries in the Asia-Pacific area are enjoying increased levels of economic growth and therefore increased levels of investments in health costs and health facilities. This growth results in better access to technologically developed medical equipment and treatment processes, especially regarding third-generation extracorporeal CO2 removal devices, particularly in tertiary care hospitals and specialized treatment institutions.
• Due to an aging population rate in countries such as Japan, Korea, China, among others, other pulmonary diseases and critical health complications associated with aging can be seen. This need for monitoring CO2 levels provides a crucial therapy for elderly patients experiencing respiratory failure which propels the growth of the extracorporeal CO2 removal devices market in the region.
• The Asia-Pacific area continues to be a more attractive location for the development of technological advancement in medical technology devices. Many companies both regional & international are directing their funding towards the Research and Development of sophisticated devices for ELSO or extracorporeal CO2 removal that corresponds to the local demands in the market. Also, there is the emerging need to embrace new health care technology that will aid in enhancing the quality of care being given to patients as well as the effectiveness of health care delivery.

Active Key Players in the Extracorporeal CO2 Removal Devices Market

• Medtronic
• Getinge
• AB
• Xenios AG
• Alung Technologies
• ESTOR S.P.A
• Medica Spa
• Aferectica Srl
• Others

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY PRODUCT (2017-2032)
   1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. EXTRACORPOREAL CO2 MACHINES
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. DISPOSABLES
   5. OTHERS
7. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY APPLICATION (2017-2032)
   1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
   5. BRIDGE TO LUNG TRANSPLANT
   6. OTHERS
8. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY END-USER (2017-2032)
   1. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. HOSPITALS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. AMBULATORY SURGICAL CENTERS
   5. CLINICS
   6. OTHERS
9. COMPANY PROFILES AND COMPETITIVE ANALYSIS
   1. COMPETITIVE LANDSCAPE
      1. Competitive Positioning
      2. Extracorporeal CO2 Removal Devices Market Share By Manufacturer (2023)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
   2. MEDTRONIC
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
   3. GETINGE
   4. AB
   5. XENIOS AG
   6. ALUNG TECHNOLOGIES
   7. ESTOR S.P.A
   8. MEDICA SPA
   9. AFERECTICA SRL
10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Product
       4. Historic And Forecasted Market Size By Application
       5. Historic And Forecasted Market Size By End-User
       6. Historic And Forecasted Market Size By Country
          1. USA
          2. Canada
          3. Mexico
    3. EASTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Russia
          2. Bulgaria
          3. The Czech Republic
          4. Hungary
          5. Poland
          6. Romania
          7. Rest Of Eastern Europe
    4. WESTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Germany
          2. United Kingdom
          3. France
          4. The Netherlands
          5. Italy
          6. Spain
          7. Rest Of Western Europe
    5. ASIA PACIFIC
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. China
          2. India
          3. Japan
          4. South Korea
          5. Malaysia
          6. Thailand
          7. Vietnam
          8. The Philippines
          9. Australia
          10. New-Zealand
          11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Turkey
          2. Bahrain
          3. Kuwait
          4. Saudi Arabia
          5. Qatar
          6. UAE
          7. Israel
          8. South Africa
    7. SOUTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Brazil
          2. Argentina
          3. Rest of South America
11. INVESTMENT ANALYSIS
12. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET COMPETITIVE RIVALRY
TABLE 005. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET THREAT OF NEW ENTRANTS
TABLE 006. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET THREAT OF SUBSTITUTES
TABLE 007. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY PRODUCT
TABLE 008. EXTRACORPOREAL CO2 MACHINES MARKET OVERVIEW (2016-2028)
TABLE 009. DISPOSABLES MARKET OVERVIEW (2016-2028)
TABLE 010. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 011. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY ACCESS
TABLE 012. VENOVENOUS ACCESS MARKET OVERVIEW (2016-2028)
TABLE 013. ARTERIOVENOUS ACCESS MARKET OVERVIEW (2016-2028)
TABLE 014. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY APPLICATION
TABLE 015. CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET OVERVIEW (2016-2028)
TABLE 016. BRIDGE TO TRANSPLANT MARKET OVERVIEW (2016-2028)
TABLE 017. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 018. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY END USER
TABLE 019. CLINICS MARKET OVERVIEW (2016-2028)
TABLE 020. SURGICAL CENTERS MARKET OVERVIEW (2016-2028)
TABLE 021. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY PRODUCT (2016-2028)
TABLE 023. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY ACCESS (2016-2028)
TABLE 024. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY APPLICATION (2016-2028)
TABLE 025. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY END USER (2016-2028)
TABLE 026. N EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY COUNTRY (2016-2028)
TABLE 027. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY PRODUCT (2016-2028)
TABLE 028. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY ACCESS (2016-2028)
TABLE 029. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY APPLICATION (2016-2028)
TABLE 030. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY END USER (2016-2028)
TABLE 031. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY COUNTRY (2016-2028)
TABLE 032. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY PRODUCT (2016-2028)
TABLE 033. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY ACCESS (2016-2028)
TABLE 034. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY APPLICATION (2016-2028)
TABLE 035. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY END USER (2016-2028)
TABLE 036. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY COUNTRY (2016-2028)
TABLE 037. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY PRODUCT (2016-2028)
TABLE 038. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY ACCESS (2016-2028)
TABLE 039. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY APPLICATION (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY END USER (2016-2028)
TABLE 041. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY COUNTRY (2016-2028)
TABLE 042. SOUTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY PRODUCT (2016-2028)
TABLE 043. SOUTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY ACCESS (2016-2028)
TABLE 044. SOUTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY APPLICATION (2016-2028)
TABLE 045. SOUTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY END USER (2016-2028)
TABLE 046. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY COUNTRY (2016-2028)
TABLE 047. MEDTRONIC: SNAPSHOT
TABLE 048. MEDTRONIC: BUSINESS PERFORMANCE
TABLE 049. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 050. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. GETINGE AB: SNAPSHOT
TABLE 051. GETINGE AB: BUSINESS PERFORMANCE
TABLE 052. GETINGE AB: PRODUCT PORTFOLIO
TABLE 053. GETINGE AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. BAXTER INTERNATIONAL INC.: SNAPSHOT
TABLE 054. BAXTER INTERNATIONAL INC.: BUSINESS PERFORMANCE
TABLE 055. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 056. BAXTER INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. XENIOS AG: SNAPSHOT
TABLE 057. XENIOS AG: BUSINESS PERFORMANCE
TABLE 058. XENIOS AG: PRODUCT PORTFOLIO
TABLE 059. XENIOS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. ALUNG TECHNOLOGIES: SNAPSHOT
TABLE 060. ALUNG TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 061. ALUNG TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 062. ALUNG TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. ESTOR SPA: SNAPSHOT
TABLE 063. ESTOR SPA: BUSINESS PERFORMANCE
TABLE 064. ESTOR SPA: PRODUCT PORTFOLIO
TABLE 065. ESTOR SPA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. MEDICA SPA: SNAPSHOT
TABLE 066. MEDICA SPA: BUSINESS PERFORMANCE
TABLE 067. MEDICA SPA: PRODUCT PORTFOLIO
TABLE 068. MEDICA SPA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. AFERECTICA SRL: SNAPSHOT
TABLE 069. AFERECTICA SRL: BUSINESS PERFORMANCE
TABLE 070. AFERECTICA SRL: PRODUCT PORTFOLIO
TABLE 071. AFERECTICA SRL: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY PRODUCT
FIGURE 012. EXTRACORPOREAL CO2 MACHINES MARKET OVERVIEW (2016-2028)
FIGURE 013. DISPOSABLES MARKET OVERVIEW (2016-2028)
FIGURE 014. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 015. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY ACCESS
FIGURE 016. VENOVENOUS ACCESS MARKET OVERVIEW (2016-2028)
FIGURE 017. ARTERIOVENOUS ACCESS MARKET OVERVIEW (2016-2028)
FIGURE 018. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY APPLICATION
FIGURE 019. CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 020. BRIDGE TO TRANSPLANT MARKET OVERVIEW (2016-2028)
FIGURE 021. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 022. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY END USER
FIGURE 023. CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 024. SURGICAL CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 025. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY COUNTRY (2016-2028)